Vaginal symptoms are one of the most common reasons women consult with physicians and
can significantly impact quality of life. 1, 2 Differential diagnosis of vaginal discharge …

Gynecologic cancers, uterine, ovarian, and vulvovaginal, affect approximately 96,000
women and result in approximately 29,000 deaths in the United States annually. In 2022, it …

Primary vaginal malignancies are rare, comprising only 2% of all female genital tract
malignancies in adults and 4.5% in children. As part of its mission to improve the quality of …

In recent years the role of diagnostic imaging by pelvic ultrasound in the diagnosis and
staging of gynecological cancers has been growing exponentially. Evidence from recent …

Primary vaginal cancer is a rare gynecologic malignancy. Given the rarity of the disease,
standardized approaches to management are limited, and a great variety of therapeutic …

We aimed to investigate human papillomavirus (HPV) prevalence and genotype distribution
and prognostic factors in vaginal cancer (VC). VC patients who received treatment between …

Mesonephric adenocarcinoma (MA) of the female genital tract is a rare but distinct entity,
exhibiting unique morphological, immunophenotypical, and molecular characteristics …

Background: Vaginal cancer is a rare disease for which prospective randomized trials do not
exist. We aimed to assess survival outcomes, patterns of recurrence, prognostic factors, and …

The European Society for Medical Oncology (ESMO) and ASCO are publishing a new
edition of the ESMO/ASCO Global Curriculum (GC) with contributions from more than 150 …

Background Primary vaginal cancer is a rare condition. Some studies have revealed an
increased risk of vaginal cancer among patients who have undergone hysterectomy for …